MARINUS PHARMACEUTICALS INC's ticker is and the CUSIP is 56854Q200. A total of 88 filers reported holding MARINUS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 3.53 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,315,403 | -26.0% | 163,404 | -0.2% | 0.00% | – |
| Q2 2023 | $1,778,543 | +395.6% | 163,770 | +214.9% | 0.00% | – |
| Q1 2023 | $358,890 | +371.7% | 52,013 | +172.1% | 0.00% | – |
| Q4 2022 | $76,085 | -41.5% | 19,117 | -1.9% | 0.00% | – |
| Q3 2022 | $130,000 | +32.7% | 19,482 | -3.8% | 0.00% | – |
| Q2 2022 | $98,000 | -91.3% | 20,262 | -83.1% | 0.00% | – |
| Q1 2022 | $1,124,000 | -21.5% | 120,205 | -0.3% | 0.00% | – |
| Q4 2021 | $1,432,000 | +5.8% | 120,536 | +1.4% | 0.00% | – |
| Q3 2021 | $1,353,000 | -26.5% | 118,897 | +15.9% | 0.00% | – |
| Q2 2021 | $1,841,000 | +24.6% | 102,627 | +7.5% | 0.00% | – |
| Q1 2021 | $1,478,000 | +37.2% | 95,455 | +8.1% | 0.00% | – |
| Q4 2020 | $1,077,000 | +28.5% | 88,297 | +35.4% | 0.00% | – |
| Q3 2020 | $838,000 | – | 65,220 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lion Point Capital, LP | 2,145,337 | $17,269,963 | 7.70% |
| Bleichroeder LP | 1,872,463 | $15,073,327 | 3.72% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,204,942 | $41,899,783 | 2.26% |
| Opaleye Management Inc. | 584,000 | $4,701,200 | 1.53% |
| Bain Capital Life Sciences Investors, LLC | 1,431,058 | $11,520,017 | 1.29% |
| Cormorant Asset Management, LP | 2,625,000 | $21,131,250 | 1.23% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 290,000 | $2,337,400 | 0.79% |
| Ikarian Capital, LLC | 746,069 | $6,005,856 | 0.72% |
| Eventide Asset Management | 4,529,997 | $36,466,476 | 0.66% |
| Altium Capital Management LP | 125,033 | $1,006,516 | 0.52% |